Filtered By:
Management: Mergers and Aquisitions
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 119 results found since Jan 2013.
A Flexible and Integrated System for the Remote Acquisition of Neuropsychological Data in Stroke Research
Telemedicine and e-Health , Vol. 0, No. 0.
Source: Telemedicine and e-Health - May 22, 2016 Category: Information Technology Authors: Corrine DuriskoMichael McCuePatrick J. DoyleMichael Walsh DickeyJulie A. Fiez Source Type: research
The Proof is in the Pudding: Does tDCS Actually Deliver DC Stimulation?
Transcranial direct current stimulation (tDCS) is an increasingly used investigational modality for a variety of disease conditions worldwide, including stroke.1 It is relatively easy-use, low-cost, and has a reasonable safety profile with currents up to 2 mA. The effect of tDCS on membrane potentials has been demonstrated in vitro2 as well as in vivo through simulation of tDCS-generated electric fields.3 Real-time monitoring of applied voltage and injected current in tDCS application is offered as an inbuilt feature of many tDCS devices and can be achieved with a simple data acquisition setup.
Source: BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation - May 10, 2016 Category: Neurology Authors: Pratik Y. Chhatbar, James R. Sawers, Wuwei Feng Source Type: research
Renee Joiner To Lead Stroke Awareness at UAMS (Movers & Shakers)
Renee Joiner has been named by the University of Arkansas for Medical Sciences in Little Rock as director of the Arkansas Stroke Awareness & Virtual Emergency Support program.
Joiner replaces Michael Manley, who in December became director of clinical service integration and development for UAMS Medical Center. For the last six years, Joiner served as trauma section chief for the Arkansas Department of Health, where she worked for 28 years.
Pete Biagioni has been named managing partner of the payer division of Cumberland Consulting Group of Franklin, Tennessee. He was president and CEO of Oleen Pinnacle Healthcare Con...
Source: Arkansas Business - Health Care - April 18, 2016 Category: American Health Source Type: news
Optimal Acquisition Settings for Speckle Tracking Echocardiography–Derived Strains in Infants: An In Vitro Study
The purpose of this study was to investigate the effect of frame rate and probe frequency on the accuracy of speckle tracking echocardiography–derived strain measurements in infants. An infant-sized left ventricle phantom with sonomicrometer crystals was made from polyvinyl alcohol. The examined stroke rates were 60, 120 and 180 strokes per min (SPM). Longitudinal strain and circumferential strain measurements were analyzed from a total of 1860 cine loops. These cine loops were acquired using two pediatric probes of different frequencies at both fundamental and harmonic imaging modes.
Source: Ultrasound in Medicine and Biology - April 12, 2016 Category: Radiology Authors: Umael Khan, Johannes Just Hjertaas, Gottfried Greve, Knut Matre Tags: Original Contribution Source Type: research
Corvia Medical wins FDA nod for trial, inks exclusive buyout deal with strategic backer
Corvia Medical said today that it won an investigational device exemption from the FDA for a clinical trial of its cardiac implant designed to treat diastolic heart failure and inked a deal with an unnamed strategic investor that includes an exclusive buyout option.
Corvia’s transcatheter InterAtrial shunt device is designed to lower blood pressure in the left atrium and lungs by creating a small opening between the left and right atria, according to Corvia’s website.
Tewksbury, Mass.-based Corvia said the 100-patient Reduce Lap-HF I study is a prospective, multicenter, randomized controlled trial. The primary ...
Source: Mass Device - March 7, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiac Implants Cardiovascular Clinical Trials Mergers & Acquisitions Corvia Medical Source Type: news
Regenerative firm Creative Medical launches cardio-focused AngioStem biz
Regenerative biotech company Creative Medical Health said today it is launching a subsidiary biz, AngioStem, to commercialize its cardiovascular assets.
Assets on hand for the newly launched company include a therapy that uses autologous and allogeneic adult stem cells in combination with modulation of oxidative stress to treat heart failure in patients with cardiovascular disease, Creative Medical Health said.
“At Creative Medical Health, our mission is to identify promising technologies, add value by strengthening the science and intellectual property surrounding the technologies, and subsequently spin off new com...
Source: Mass Device - February 29, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Cardiovascular Regenerative Medicine AngioStem Creative Medical Health Source Type: news
CT perfusion in acute stroke calls: A pictorial review and differential diagnoses
Summary
CT perfusion is increasingly utilised in hyperacute stroke to facilitate diagnosis and patient selection for reperfusion therapies. This review article demonstrates eight examples of how CT perfusion can be used to diagnose stroke mimics and small volume infarcts, which can be easily missed on non‐contrast CT, and to suggest the presence of an ischaemic penumbra. Radiologists involved in stroke management must understand the importance of rapid imaging acquisition and be confident in the prospective interpretation of this powerful diagnostic tool as we move into a new era of hyperacute stroke care.
Source: Australasian Radiology - December 2, 2015 Category: Radiology Authors: Albert H Chiu, Timothy J Phillips, Constantine C Phatouros, Tejinder P Singh, Graeme J Hankey, David J Blacker, William McAuliffe Tags: Medical Imaging—Review Article Source Type: research
Fungal Infections of the Central Nervous System
This article summarizes current knowledge on the epidemiology, clinical presentations, diagnosis, and management of selected fungal infections of the central nervous system (CNS). Key syndromes, differential diagnoses, and therapeutic interventions according to host immune status and exposure are reviewed.
Recent Findings:: Advancements in imaging of the brain and spinal cord, and molecular DNA and antigen-based laboratory diagnostics afford improved sensitivity for CNS mycoses. Newer therapeutic strategies may improve outcomes if provided early and host immunosuppression is abrogated. Adjunctive corticosteroid use for dis...
Source: CONTINUUM - December 1, 2015 Category: Neurology Tags: Review Articles Source Type: research
Ultrafast ultrasound localization microscopy for deep super-resolution vascular imaging
; Mickael Tanter
Non-invasive imaging deep into organs at microscopic scales remains an open quest in biomedical imaging. Although optical microscopy is still limited to surface imaging owing to optical wave diffusion and fast decorrelation in tissue, revolutionary approaches such as fluorescence photo-activated localization microscopy led to a striking increase in resolution by more than an order of magnitude in the last decade. In contrast with optics, ultrasonic waves propagate deep into organs without losing their coherence and are much less affected by in vivo decorrelation processes. However, their resolution is...
Source: Nature - November 25, 2015 Category: Research Authors: Claudia ErricoJuliette PierreSophie PezetYann DesaillyZsolt LenkeiOlivier CoutureMickael Tanter Tags: Letter Source Type: research
J&J’s Biosense Webster buys Coherex Medical and its WaveCrest anti-stroke device
Johnson & Johnson (NYSE:JNJ) subsidiary Biosense Webster said today that it acquired Coherex Medical for an undisclosed amount.
Salt Lake City-based Coherex makes the Wavecrest anti-stroke device, which is designed to occlude the heart’s left atrial appendage to prevent blood clots from forming that could cause stroke.
“The addition of the Coherex WaveCrest system complements our comprehensive portfolio of therapeutic solutions for patients suffering from atrial fibrillation who not only suffer from reduced quality of life but also face a significantly greater risk of a stroke,” group chairman Shlomi...
Source: Mass Device - November 20, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiac Implants Cardiovascular Mergers & Acquisitions BioSense Webster Inc. Coherex Medical Johnson & Johnson Source Type: news
Nipro to sell diagnostics biz to China’s Sinocare for $273m
Nipro (TYO: 8086) said today it signed a deal sell its diagnostics business to China-based Sinocare for approximately $273 in cash.
Nipro Diagnostics, based in Ft. Lauderdale, Fla., develops, manufactures and markets diabetes products, including glucose monitors, the company said.
“This transaction combines 1 of the fastest growing blood glucose monitoring companies in the United States with the fastest growing blood glucose monitoring company in China. We have a shared vision and a singular focus to provide innovative and affordable solutions so patients can live healthier lives. Together, we will offer a strong p...
Source: Mass Device - October 27, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Diabetes Diagnostics Mergers & Acquisitions Nipro Sinocare Source Type: news
Medtronic acquires stent retriever cover-dev Lazarus Effect for $100m
Medtronic (NYSE:MDT) said today it acquired Campbell, Calif.-based stent-retriever cover developer Lazarus Effect for $100 million in an all-cash transaction.
Lazarus’ Cover device is designed to wrap stent retriever devices with a novel nitinol “mesh cover” that folds over the retreiver during clot retrieval and “candy wraps” the stent with the clot contained, Fridely, Minn.-based Medtronic said.
“With this acquisition, Medtronic reinforces its commitment to providing innovative solutions to clinicians and patients fighting stroke. Lazarus Effect’s ‘mesh cover’ techno...
Source: Mass Device - September 28, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Mergers & Acquisitions Stents Vascular Medtronic Source Type: news
Nipro to acquire Infraredx
Nipro (TYO: 8086) said today that it plans to acquire Infraredx and its cardiovascular imaging device for an undisclosed amount.
Burlington, Mass.-based Infraredx makes an imaging system that combines intravascular ultrasound and near-infrared spectroscopy to provide images of the interior of coronary blood vessels. The company says the device is designed to detect lipid-core-containing plaque, which it says is implicated in higher risk for heart attack or stroke.
In 2013 Nipro put down a $25 million equity investment in Infraredx, which earlier this year withdrew an initial public offering it had hoped would raise $56...
Source: Mass Device - September 11, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiovascular Imaging Mergers & Acquisitions InfraReDx Inc. Nipro Source Type: news
Medtronic pays $150m for Medina Medical
Medtronic (NYSE:MDT) yesterday said it agreed to pay $150 million to acquire Medina Medical and its embolization coil for treating brain aneurysms.
The Medina device is a self-expanding mesh designed to fill the inside of an aneurysm. Menlo Park, Calif.-based Medina won CE Mark approval in the European Union for the device in September 2014, a month after naming ex-Foundry partner Erik Engelson to be its new CEO. Back in October 2012, the company raised more than $6.5 million in an equity offering that aimed to raise $9.5 million.
Medtronic said it already owned a stake in Medina, meaning a pre-tax gain for its 2n...
Source: Mass Device - September 1, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Mergers & Acquisitions Neurological Vascular Medina Medical medtronic Source Type: news
